Peptide-based vaccines, methods of manufacturing, and uses thereof for inducing an immune response

US12370255B2 · kind B2 · utility

Assignees

• BARINTHUS BIOTHERAPEUTICS NORTH AMERICA, INC. · US
• THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · US

Inventors

• Geoffrey Lynn · Baltimore, US
• Andrew Scott Ishizuka · Washington, US

Key dates

• Filing date: Apr 4, 2018
• Grant date: Jul 29, 2025
• Expiry date: Sep 8, 2039

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C12N2740/16034
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present disclosure relates to novel peptide-based vaccines, methods of manufacturing the novel peptide-based vaccines and uses thereof for delivering peptide antigens to induce an immune response, and in particular a T cell response to a subject.